Paid Clinical Trials in West Valley City, UT
As of June 2026, 74 paid clinical trials are recruiting in West Valley City, Utah. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
West Valley City offers studies at sites including START Mountain Region for conditions such as Advanced Solid Tumor, Solid Tumor, Triple Negative Breast Cancer, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in West Valley City
Trials by drug in West Valley City
Filter results
74 clinical trials
↓ Download CSVDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Study in Advanced Solid Tumor Patients
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
First-in-human Study of 7MW4911 in GI Cancer
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
A Study of LY4175408 in Participants With Advanced Cancer
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
The Beat Pain Better Trial
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
A Study of MGC028 in Participants With Advanced Solid Tumors
About research studies in West Valley City
West Valley City has approximately 74 recruiting research studies across a wide range of therapeutic areas. Utah hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in West Valley City
Researchers run research studies in West Valley City, UT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| START Mountain Region | Advanced Solid Tumor, Colorectal Cancer, Gastric Cancer | 36 |
| START Mountain | Advanced Solid Tumor, Advanced Breast Cancer, Breast Neoplasms | 4 |
| GSK Investigational Site | Neoplasms, Neoplasms, Prostate, Solid Tumors | 3 |
| Kalo Clinical Research | Diabetes Mellitus, Type 2, Metabolic Syndrome, Obesity | 2 |
| START Mountain Region, LLC | Adenocarcinoma of Esophagus, Biliary Tract Carcinoma, Bladder Cancer | 2 |
| START Mountain Region, LLC. | Advanced Solid Tumor, Metastatic Solid Tumor, Participants With Advanced Solid Tumor Malignancies | 2 |
| START Moutain Region | GI Cancers, Glioma, MAPK Pathway Gene Mutation | 2 |
| South Texas Accelerated Research Therapeutics (START) Mountain Region | Advanced Solid Tumors, CCNE1 Amplified Advanced Solid Tumors, Cholangiocarcinoma | 2 |
| ALX Center 4 | CRC (Colorectal Cancer), Colo-rectal Cancer, ESCC | 1 |
| Avenzo Therapeutics Recruiting Site | Biliary Tract Cancer (BTC), Epithelial Tumor, Locally Advanced | 1 |
| Baxis | Bacterial Conjunctivitis | 1 |
| Biotheryx Investigative Site | Breast Cancer | 1 |
| ChronicleBio | Chronic Migraine, Episodic Migraine | 1 |
| Clinical Study Site | Locally Advanced / Metastatic Solid Tumors | 1 |
| Holy Cross Hosp Jordan Valley West | Lumbar Spinal Stenosis | 1 |
| Jordan Valley Med Ctr West Valley | Lumbar Spinal Stenosis | 1 |
| Kalo Clinical Research - West Valley City | Diabetic Peripheral Neuropathic Pain | 1 |
| START - Mountain Region | Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | 1 |
| START Center for Cancer Care | Advanced Solid Tumor | 1 |
| START Center for Cancer Research | Breast Cancer, Cervical Cancer, Endometrial Cancer | 1 |
| START Mountain Region | Non-Hodgkin's Lymphoma | 1 |
| START Mountan Region | Advanced Solid Tumor | 1 |
| START, Mountain Region | Breast Cancer, Colo-rectal Cancer, Lung Cancer (Non-Small Cell) | 1 |
| South Texas Accelerated Research Therapeutics Mountain Region | Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Gastroesophageal Junction Adenocarcinoma | 1 |
| Vamos Health | Chronic Pain Management, Osteoarthritis | 1 |
Active & Upcoming Studies in West Valley City (2026)
Recruiting trials in West Valley City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (53 active studies)
- Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors · Phase 1 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
- Study in Advanced Solid Tumor Patients · Phase 1, Phase 2 · Callio Therapeutics
Neurology & pain (3 active studies)
- The Beat Pain Better Trial · Phase 3 · University of Utah
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults · Phase 2 · Ipsen
Diabetes & metabolic (2 active studies)
- A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes · Phase 2 · Eli Lilly and Company
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · Cleerly, Inc.
Common conditions studied in West Valley City
- Advanced Solid Tumor (12 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Solid Tumor (7 active studies). Recruiting Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Triple Negative Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Breast Cancer (5 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Ovarian Cancer (5 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
- Pancreatic Cancer (5 active studies). Pancreatic cancer studies investigate new chemotherapy backbones, targeted inhibitors, and combination approaches to improve historically poor outcomes.
Leading research sponsors in West Valley City
- Eli Lilly and Company
- AbbVie
- GlaxoSmithKline
- Biohaven Therapeutics Ltd.
- Bristol-Myers Squibb
Local regulations and guidelines
Clinical trials in Utah are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Utah research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in West Valley City. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in West Valley City
Hipa.ai aggregates every recruiting study in West Valley City from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in West Valley City?
There are approximately 74 recruiting clinical trials in West Valley City, Utah listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in West Valley City pay participants?
Most recruiting trials in West Valley City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in West Valley City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in West Valley City?
The most common conditions under active study in West Valley City include Advanced Solid Tumor (12), Solid Tumor (7), Triple Negative Breast Cancer (6), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in West Valley City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in West Valley City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in West Valley City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in West Valley City?
Recruiting research sites in West Valley City include START Mountain Region, START Mountain, GSK Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in West Valley City right now?
The largest active categories in West Valley City are Cancer & tumors (53), Neurology & pain (3), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.